
The Cardiac Stents and Catheters Manufacturing Plant Project is an advanced industrial and medical initiative aimed at establishing a specialized production unit for high-precision medical devices used in the treatment of cardiovascular diseases. These include coronary stents and balloon catheters, manufactured to meet international technical standards and quality specifications.
This project is considered strategic due to the critical role these devices play in non-surgical interventions for coronary artery blockage or narrowing. Stents help keep arteries open and restore proper blood flow to the heart, while balloon catheters are used to widen and rehabilitate arteries efficiently and effectively.
The plant will adopt cutting-edge medical and engineering technologies in its production processes, using biocompatible medical-grade materials that undergo rigorous testing to ensure safety and effectiveness. The project complies with global quality standards, including ISO and FDA certifications.
Manufacturing will follow a multi-stage process, beginning with precise engineering design, followed by advanced production, sterilization, and finally, performance and reliability testing—all with the goal of delivering medical products that meet the needs of both local and global markets for high-quality cardiovascular devices.
The global cardiovascular stents and catheters market was valued at approximately USD 11.65 billion in 2024, and it is expected to witness accelerated growth in the coming years, driven by the rising prevalence of heart diseases and advancements in medical device technologies. Estimates project that the market will reach USD 22.90 billion by 2032, with a compound annual growth rate (CAGR) of around 8.9% between 2025 and 2032. This reflects the increasing global reliance on interventional treatments as an effective approach to managing coronary artery disease.
In parallel, statistics show that the cardiac catheters market continues to expand globally, with its value expected to reach approximately USD 26.7 billion by 2030, indicating robust demand for innovative cardiovascular treatment tools.
The Cardiac Stents and Catheters Manufacturing Project in the Kingdom of Saudi Arabia is gaining increasing strategic importance due to the rising incidence of cardiovascular diseases, which are among the leading causes of death and chronic disability in the country. This project aligns with the Kingdom’s broader efforts to develop the healthcare sector and achieve self-sufficiency in the field of vital biomedical devices. It contributes to reducing dependency on imports, lowering costs, and accelerating the availability of these essential products to hospitals and patients.
Moreover, the project supports the realization of Saudi Vision 2030, which focuses on advancing the local medical manufacturing industry and creating new job opportunities for citizens, thereby enhancing the national economy and improving healthcare services.
According to projections, the market size for cardiac stents and catheters in Saudi Arabia is expected to reach approximately SAR 863.61 million by the end of 2025, with estimates indicating an increase to around SAR 1,402.65 million by 2033. This reflects the rapidly growing demand for these critical medical devices.
Get a Feasibility Study